is retatrutide a triple agonist 🎙️ NEW EPISODE: Retatrutide—The *Not licensed* Will this replace the current GLP-1 in the market. This triple receptor agonist (GIP/GLP-1/glucagon) showing unprecedented results in weight loss trials, outperforming current Lilly's triple agonist, retatrutide, delivered

First, lets be clear: GLP-1s arent targeting the fat pads in your face specifically

[11] The hypothesis underlying microdosing is that lower doses might provide some metabolic benefit whilst minimising these troublesome symptoms, potentially improving treatment adherence

1.5 Literature and methodology This review uses a structured narrative evidence synthesis as its primary method of evidence integration

High blood sugar, insulin levels, and inflammation from obesity can cause cancer

Batchuluun B, Inoguchi T, Sonoda N, Sasaki S, Inoue T, Fujimura Y, Miura D, Takayanagi R: Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells